| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology2 Department of Pharmacology, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK
Adenoviral vectors (AVVs) and lentiviral vectors (LVVs) are highly useful research tools which can be used to investigate the function of specific cell phenotypes in the brain. The transductional tropism of viral vectors has a critical impact upon the transgene expression in different brain areas. This largely depends on the properties of the viral particles, which for AVVs are most commonly analogous to the serotype 5 adenovirus and, in the case of LVVs, are determined by the envelope used for pseudotyping, for example the vesicular stomatitis virus coat (VSVG). We have created a matching set of shuttle plasmids that allow a one-step transfer of an entire expression cassette between the backbones of AVVs and LVVs. This has permitted a fair assessment of the impact of the vector type on tropism for both AVVs and LVVs. Thus, the aims of this study were twofold: (i) to develop and demonstrate the validity of a transgene ‘swap’ system between AVVs and LVVs; and (ii) using this system, to assess the tropism of AVVs and LVVs for neuronal versus glial cell types. We have constructed AVVs and VSVG-coated LVVs to express monomeric red fluorescent protein (mRFP) driven by the human cytomegalovirus promoter (hCMV). Transgene expression in neurones and glia in the hypoglossal and dorsal vagal motor nuclei of the rat brainstem was compared by determining the colocalization with immunostaining for the neuronal marker NeuN (neuronal nuclear antigen) and the glial marker GFAP (glial fibrillatory acidic protein). We found that 55% of mRFP-expressing cells transduced with AVVs were immunopositive for GFAP, while only 38% were NeuN-immunoreactive. In contrast, when the same expression cassette was delivered by VSVG-coated LVVs, the neurone/glia ratio of mRFP expression was reversed with 56% of mRFP-positive cells identified as neurones and 26% as glia. Thus, the present study provides compelling evidence that VSVG-coated LVVs significantly shift transgene expression towards neurones while transduction with AVVs favours glia.
(Received 4 October 2004;
accepted after revision 20 October 2004; first published online 12 November 2004)
Corresponding author A. G. Teschemacher: Department of Pharmacology, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK. Email: anja.teschemacher{at}bristol.ac.uk
This article has been cited by other articles:
|
|
 |
|
  M. D. White, M. Farmer, I. Mirabile, S. Brandner, J. Collinge, and G. R. Mallucci Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease PNAS, July 22, 2008; 105(29): 10238 - 10243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Kelley, K. A. Kaproth-Joslin, S. E. Reks, A. V. Smrcka, and R. J. H. Wojcikiewicz G-protein-coupled Receptor Agonists Activate Endogenous Phospholipase C{epsilon} and Phospholipase Cbeta3 in a Temporally Distinct Manner J. Biol. Chem., February 3, 2006; 281(5): 2639 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Norris, I. Kadish, E. M. Blalock, K.-C. Chen, V. Thibault, N. M. Porter, P. W. Landfield, and S. D. Kraner Calcineurin Triggers Reactive/Inflammatory Processes in Astrocytes and Is Upregulated in Aging and Alzheimer's Models J. Neurosci., May 4, 2005; 25(18): 4649 - 4658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Teschemacher, S. Wang, T. Lonergan, H. Duale, H. Waki, J. F. R. Paton, and S. Kasparov Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function Exp Physiol, January 1, 2005; 90(1): 61 - 69. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
